Delivery Order SPE2DB22D2206-SPE2DB25FJJ02
- Not listed
- The Defense Logistics Agency awarded a $1,765.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2ML) on July 21, 2025, with completion expected by July 22, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,047.98 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2mL) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price, competitively awarded delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December...
- The Defense Logistics Agency awarded a delivery order valued at $2,653.69 to AmerisourceBergen Drug Corp for VEVYE 0.1% eye drop solution (2mL) under a firm fixed price contract with an ultimate completion date of July 31, 2025. The award was made on July 30, 2025, without set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for VEVYE 0.1% eye drop in a 2ml formulation, with a ceiling value of $1,047.98. This competitive delivery order, issued under a firm fixed price arrangement, represents a continuation of pharmaceutical supply support through AmerisourceBergen's broader federal contracting relationship. The award carries no set-aside designation and is set for ultimate completion by August 6, 2025, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor based in Conshohocken, Pennsylvania, for supply of VEVYE 0.1% eye drops in 2ML units. This firm fixed-price delivery order, valued at $6,967.04, was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The award represents a continuation of the company's role as a critical vendor within the federal medical supply chain,...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,172.80 firm fixed-price delivery order is for VEVYE 0.1% eye drops, with a period of performance through March 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This delivery order, valued at $3,143.94, was awarded to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Vevye 0.1% eye drops in 2ML units to support federal medical procurement needs. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively through the Defense Logistics Agency (DLA). The work is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25,...
- This delivery order, issued on July 30, 2025, awards AmerisourceBergen Drug Corp a firm fixed-price contract valued at $4,203.19 to supply VEVYE 0.1% Eye Drop (2mL) to the Defense Logistics Agency (DLA). The contract is categorized as a child contract under a larger vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 31, 2025. This award was competitively awarded with no set-aside designation,...
- This is a $7,135.22 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of VEVYE 0.1% EYE DROP 2ML, a pharmaceutical product, with a performance period ending on July 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VEVYE 0.1% EYE DROP 2ML, a medical product, with a ceiling value of $2,738.43 and a period of performance through May 13, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJJ02Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,959.60 to AmerisourceBergen Drug Corp for VEVYE 0.1% Eye Drop (2ML) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related commodities to support military healthcare programs globally. The company's federal contract awards demonstrate its capability to fulfill diverse medical procurement requirements through open competition, serving multiple federal customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 8/11/25 |